Latest News

Boosting Vitamin E Intake May Protect Against MASLD


 

TOPLINE:

Augmenting an intake of vitamin E, via both diet and supplements, may help prevent metabolic dysfunction–associated steatotic liver disease (MASLD), particularly in adults without hyperlipidemia, new data showed.

METHODOLOGY:

  • MASLD (formerly known as nonalcoholic fatty liver disease) is a common chronic liver disease, and its severe form — metabolic dysfunction–associated steatohepatitis (formerly nonalcoholic steatohepatitis) — is associated with oxidative stress. As an antioxidant, vitamin E may protect against MASLD.
  • Researchers analyzed data for 6122 adults from the National Health and Nutrition Examination Survey from 2017 to 2020.
  • Information on dietary, supplementary, and total vitamin E intake was obtained from two 24-hour dietary recall interviews.
  • The extent of hepatic steatosis was measured by liver ultrasound transient elastography, with MASLD defined as a controlled attenuated parameter threshold of ≥ 288 dB/m.

TAKEAWAY:

  • After adjustment for sociodemographic characteristics, adults with MASLD had lower dietary and total intake of vitamin E, and dietary and total vitamin E intake was inversely associated with MASLD outcome.
  • Adults in the top quartile of dietary vitamin E intake had approximately 40% lower odds of MASLD (odds ratio [OR], 0.60; P = .0091).
  • Vitamin E supplement use was associated with 34% reduced odds of MASLD (OR, 0.66; P = .0249), whereas adults in the top quartile of total vitamin E intake had a 33% lower likelihood of MASLD (OR, 0.67; P = .0538).
  • The findings were robust to sensitivity analysis, and the effects were stronger in those without hyperlipidemia.

IN PRACTICE:

“Increasing dietary sources of vitamin E is beneficial for preventing [MASLD], particularly in individuals without hyperlipidemia,” the researchers concluded.

SOURCE:

The study, with first author Xiangjun Qi, Guangzhou University of Chinese Medicine, Guangzhou, China, was published online in Scientific Reports.

LIMITATIONS:

Causality cannot be determined due to the cross-sectional study design. Dietary recalls may not fully reflect the dietary status of participants, which may influence assessment of exposure to some extent.

DISCLOSURES:

The study had no specific funding. The authors declared no conflicts of interest.

A version of this article appeared on Medscape.com.

Recommended Reading

FDA approves first 2 gene-editing therapies for sickle cell
MDedge Internal Medicine
MASLD often is worse in slim patients
MDedge Internal Medicine
Screening for alcohol use disorder cuts hospital readmission
MDedge Internal Medicine
Is There a Safe Alcohol Limit in Early Liver Disease?
MDedge Internal Medicine
New Guideline Offers Recommendations for Alcohol-Associated Liver Disease
MDedge Internal Medicine
NEJM Study Highlights Resmetirom’s Efficacy in NASH With Liver Fibrosis
MDedge Internal Medicine
Pretreatment Lab Testing for Chronic Skin Diseases Diverges From Guidelines
MDedge Internal Medicine
Undiagnosed Cirrhosis May Underlie Some Dementia Cases
MDedge Internal Medicine
Alcohol-Related Liver Disease Mortality Higher in Women
MDedge Internal Medicine
CRC: Troubling Mortality Rates for a Preventable Cancer
MDedge Internal Medicine